A Study to Compare Two Anti-HIV Drug Combinations That Include Amprenavir in HIV-Infected Patients Who Have Failed Anti-HIV Drug Combinations That Did Not Include Amprenavir

PHASE2CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

March 31, 1999

Conditions
HIV Infections
Interventions
DRUG

Indinavir sulfate

DRUG

Abacavir sulfate

DRUG

Amprenavir

DRUG

Nelfinavir mesylate

DRUG

Lamivudine

Trial Locations (8)

10011

Bentley-Salick Med Practice, New York

20007

Georgetown Univ Med Ctr, Washington D.C.

20892

Natl Institute of Allergy and Infectious Diseases, Bethesda

32701

IDC Research Initiative, Altamonte Springs

64111

Kansas City AIDS Research Consortium, Kansas City

74114

Associates in Med and Mental Health, Tulsa

94109

Saint Francis Mem Hosp, San Francisco

972109951

Portland Veterans Adm Med Ctr / Rsch & Education Grp, Portland

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Glaxo Wellcome

INDUSTRY